Moderna says its Covid vaccine is ‘well tolerated’ in 6- to 11-year-olds after fears of heart inflammation in young adults — RT World News

Moderna Inc has claimed that its mRNA Covid vaccine is “well tolerated” in children between the ages of six to 11, and announced that the firm plans to submit the data from its study to regulatory bodies worldwide shortly.

The company released a statement Monday stating that interim data from the KidCOVE Phase 2/3 study had shown the vaccine was produced. “robust neutralizing antibody response.”

Two doses of half-sized jabs were administered to healthy children aged six through eleven who took part in the study. They were 28 days apart. According to the notice the jab is administered twice daily. “was generally well tolerated with a safety and tolerability profile generally consistent with the Phase 3 COVE study in adolescents and adults.” also available
According to a US regulator, there is an increased chance of developing heart disease from Moderna Covid jabs given to young men after suspensions in Nordic states

Moderna stated that the majority of side effects were either mild or moderate. The most frequent side effects include fatigue, headaches, fever and pain at the injection site.

Moderna Chief Executive Officer Stephane Bancel said that Moderna is “looking forward”. “forward to filing with regulators globally and [remains] committed to doing our part to help end the COVID-19 pandemic with a vaccine for adults and children of all ages.”

The recruitment for the cohort of six- to twelve year olds, in which 4,753 participants participated, is now complete. “continues to enroll children [aged] six months to under six years of age.” also available
Iceland has stopped using Moderna’s Covid vaccination for everyone over concerns about heart inflammation.

The publication of the firm’s findings comes shortly after a handful of Nordic nations decided to suspend their usage of the vaccine to some extent earlier this month, citing concerns over heart inflammation in young adults.

Iceland’s health authorities fully halted the use of Moderna’s Covid vaccine for all ages, while Sweden put a pause on the company’s jab, marketed as Spikevax, for all young people under 30. Norway suggested that young men of Finnish descent choose Pfizer over this vaccine. Finland followed a similar path.

Share this article with friends if you enjoy it!



Related Articles

Back to top button